See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Baseball
Natural Disasters
Stock Markets
Social Media
Tariffs
UK Economy
Taxes
Soccer
Donald Trump
Education
Senate
Artificial Intelligence
Published • loading... • Updated

#Merit Medicals WRAPSODY Cell-Impermeable Endoprosthesis 12-Month Efficacy Results Amid Market Performance Analysis

Summary by csimarket.com
Merit Medical Systems Inc, a prominent player in the medical device industry, recently announced the 12-month efficacy results of its WRAPSODY Cell-Impermeable Endoprosthesis (CIE). As the healthcare sector increasingly focuses on innovative solutions for vascular issues, this release presents an opportunity to examine both the clinical implications of the WRAPSODY CIE and its stock performance amidst current market trends. 'Efficacy of the WRAP…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
csimarket.comcsimarket.com

#Merit Medicals WRAPSODY Cell-Impermeable Endoprosthesis 12-Month Efficacy Results Amid Market Performance Analysis

Merit Medical Systems Inc, a prominent player in the medical device industry, recently announced the 12-month efficacy results of its WRAPSODY Cell-Impermeable Endoprosthesis (CIE). As the healthcare sector increasingly focuses on innovative solutions for vascular issues, this release presents an opportunity to examine both the clinical implications of the WRAPSODY CIE and its stock performance amidst current market trends. 'Efficacy of the WRAP…

Read Full Article
Interventional NewsInterventional News

One-year WAVE trial results show patency advantage for Wrapsody versus PTA - Interventional News

Merit Medical Systems has announced that the six-month results from the randomised arm of the Wrapsody arteriovenous access efficacy—WAVE—trial are scheduled for publication in the April issue of Kidney International, ahead of the presentation of 12-month results from the trial at the Society of Interventional Radiology’s 50th annual scientific meeting (29 March–2 April, Nashville, USA). The creation of an arteriovenous fistula (AVF) to achieve …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Interventional News broke the news in on Tuesday, March 25, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Nashville, Tennessee

Nashville, Tennessee

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal